The facility will create total employment for around 750 people
Indian Immunologicals Limited (IIL) announced that the company will invest about Rs 700 crores to set up a new animal vaccine manufacturing facility in Genome Valley, Hyderabad – the “Vaccine Hub of the World”, to meet the vaccine security of the nation against economically important diseases such as Foot and Mouth disease (FMD) and other emerging diseases. The facility will create total employment for around 750 people.
IIL is investing in a new greenfield project for the establishment of a Veterinary Vaccine Facility for manufacturing of Foot and Mouth Disease (FMD) vaccine and other animal vaccines. The facility is intended to be a state-of-art fully integrated biosafety level 3 (BSL-3) for Drug substance (DS) production and respective fill-finish.
IIL’s intended new facility, in Genome Valley Phase 3, will add another 300 million doses/annum of FMD vaccine to its capacity. The existing facility in Gachibowli already has a capacity of 300 million doses. Production is scheduled to commence in the 3rd year.
All of these activities will be located in Genome Valley, which is India’s first organized cluster for Life Sciences R&D and Clean Manufacturing activities, with world-class infrastructure facilities in the form of Industrial / Knowledge Parks, Special Economic Zones (SEZs), Multi-tenanted dry and wet laboratories and incubation facilities. It is home to more than 200 companies with a scientific workforce of about 15,000 professionals including the presence of marquee global names like Novartis, GlaxoSmithKline, Ferring Pharma, Chemo, DuPont, Ashland, United States Pharmacopeia, Lonza amongst many others including other vaccines manufacturers like Bharat Biotech, Biological E, etc.
Dr K Anand Kumar, MD, IIL, and other members of the Executive Leadership team of IIL including Senior Vice Presidents Mukul Gaur and NSN Bhargav met Minister KT Rama Rao and briefed him on the company’s plans. Jayesh Ranjan, Principal Secretary, Industries & Commerce and Shakthi M Nagappan, Director (Pharma & Lifesciences), Government of Telangana were also present during the meeting.
